3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
25,169
|
29,057
|
|
|
|
受取手形
|
137
|
90
|
|
|
|
売掛金
|
28,814
|
30,671
|
|
|
|
契約資産
|
702
|
821
|
|
|
|
有価証券
|
23,485
|
25,367
|
|
|
|
商品及び製品
|
13,706
|
12,463
|
|
|
|
仕掛品
|
199
|
790
|
|
|
|
原材料及び貯蔵品
|
11,074
|
12,268
|
|
|
|
その他
|
3,689
|
3,437
|
|
|
|
流動資産合計
|
106,980
|
114,969
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物
|
39,422
|
41,745
|
|
|
|
|
|
減価償却累計額
|
△30,845
|
△30,703
|
|
|
|
|
|
建物及び構築物(純額)
|
8,577
|
11,042
|
|
|
|
|
土地
|
13,067
|
10,695
|
|
|
|
|
建設仮勘定
|
2,015
|
543
|
|
|
|
|
その他
|
17,342
|
20,569
|
|
|
|
|
|
減価償却累計額
|
△13,932
|
△14,758
|
|
|
|
|
|
その他(純額)
|
3,410
|
5,811
|
|
|
|
|
有形固定資産合計
|
27,069
|
28,093
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
ソフトウエア
|
1,487
|
1,703
|
|
|
|
|
のれん
|
242
|
176
|
|
|
|
|
その他
|
164
|
89
|
|
|
|
|
無形固定資産合計
|
1,894
|
1,969
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
84,869
|
104,271
|
|
|
|
|
長期貸付金
|
5
|
4
|
|
|
|
|
長期前払費用
|
12,708
|
10,814
|
|
|
|
|
退職給付に係る資産
|
8,804
|
13,287
|
|
|
|
|
繰延税金資産
|
566
|
538
|
|
|
|
|
その他
|
1,178
|
1,157
|
|
|
|
|
貸倒引当金
|
△18
|
△18
|
|
|
|
|
投資その他の資産合計
|
108,115
|
130,055
|
|
|
|
固定資産合計
|
137,079
|
160,117
|
|
|
資産合計
|
244,059
|
275,086
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
支払手形及び買掛金
|
4,602
|
6,661
|
|
|
|
短期借入金
|
1,280
|
1,250
|
|
|
|
未払法人税等
|
1,474
|
5,006
|
|
|
|
賞与引当金
|
2,183
|
2,298
|
|
|
|
役員賞与引当金
|
9
|
-
|
|
|
|
販売費引当金
|
129
|
129
|
|
|
|
契約負債
|
1,033
|
846
|
|
|
|
その他
|
5,866
|
5,494
|
|
|
|
流動負債合計
|
16,578
|
21,688
|
|
|
固定負債
|
|
|
|
|
|
繰延税金負債
|
16,481
|
21,029
|
|
|
|
役員退職慰労引当金
|
202
|
220
|
|
|
|
資産除去債務
|
149
|
130
|
|
|
|
その他
|
520
|
482
|
|
|
|
固定負債合計
|
17,354
|
21,862
|
|
|
負債合計
|
33,933
|
43,550
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
24,356
|
24,356
|
|
|
|
資本剰余金
|
24,226
|
24,243
|
|
|
|
利益剰余金
|
131,488
|
136,253
|
|
|
|
自己株式
|
△14,520
|
△15,513
|
|
|
|
株主資本合計
|
165,550
|
169,339
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
38,752
|
54,076
|
|
|
|
退職給付に係る調整累計額
|
4,701
|
6,730
|
|
|
|
その他の包括利益累計額合計
|
43,453
|
60,806
|
|
|
非支配株主持分
|
1,122
|
1,390
|
|
|
純資産合計
|
210,126
|
231,536
|
|
負債純資産合計
|
244,059
|
275,086
|
E00962
45470
キッセイ薬品工業株式会社
KISSEI PHARMACEUTICAL CO., LTD.
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-04-01
2026-03-31
FY
2026-03-31
2024-04-01
2025-03-31
2025-03-31
1
false
false
false
45470
2026-05-11
45470
2025-04-01
2026-03-31
45470
2025-04-01
2026-03-31
jppfs_cor:CapitalStockMember
45470
2025-04-01
2026-03-31
jppfs_cor:CapitalSurplusMember
45470
2025-04-01
2026-03-31
jppfs_cor:NonControllingInterestsMember
45470
2025-04-01
2026-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45470
2025-04-01
2026-03-31
jppfs_cor:RetainedEarningsMember
45470
2025-04-01
2026-03-31
jppfs_cor:ShareholdersEquityMember
45470
2025-04-01
2026-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
45470
2025-04-01
2026-03-31
jppfs_cor:TreasuryStockMember
45470
2025-04-01
2026-03-31
tse-acedjpfr-45470:InformationServiceReportableSegmentsMember
45470
2025-04-01
2026-03-31
tse-acedjpfr-45470:PharmaceuticalProductsReportableSegmentsMember
45470
2025-04-01
2026-03-31
tse-acedjpfr-45470:TradingBusinessReportableSegmentMember
45470
2025-04-01
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45470
2025-04-01
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45470
2026-03-31
45470
2026-03-31
jppfs_cor:CapitalStockMember
45470
2026-03-31
jppfs_cor:CapitalSurplusMember
45470
2026-03-31
jppfs_cor:NonControllingInterestsMember
45470
2026-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45470
2026-03-31
jppfs_cor:RetainedEarningsMember
45470
2026-03-31
jppfs_cor:ShareholdersEquityMember
45470
2026-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
45470
2026-03-31
jppfs_cor:TreasuryStockMember
45470
2026-03-31
tse-acedjpfr-45470:InformationServiceReportableSegmentsMember
45470
2026-03-31
tse-acedjpfr-45470:PharmaceuticalProductsReportableSegmentsMember
45470
2026-03-31
tse-acedjpfr-45470:TradingBusinessReportableSegmentMember
45470
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45470
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45470
2024-04-01
2025-03-31
45470
2024-04-01
2025-03-31
jppfs_cor:CapitalStockMember
45470
2024-04-01
2025-03-31
jppfs_cor:CapitalSurplusMember
45470
2024-04-01
2025-03-31
jppfs_cor:NonControllingInterestsMember
45470
2024-04-01
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45470
2024-04-01
2025-03-31
jppfs_cor:RetainedEarningsMember
45470
2024-04-01
2025-03-31
jppfs_cor:ShareholdersEquityMember
45470
2024-04-01
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
45470
2024-04-01
2025-03-31
jppfs_cor:TreasuryStockMember
45470
2024-04-01
2025-03-31
tse-acedjpfr-45470:InformationServiceReportableSegmentsMember
45470
2024-04-01
2025-03-31
tse-acedjpfr-45470:PharmaceuticalProductsReportableSegmentsMember
45470
2024-04-01
2025-03-31
tse-acedjpfr-45470:TradingBusinessReportableSegmentMember
45470
2024-04-01
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45470
2024-04-01
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45470
2025-03-31
45470
2025-03-31
jppfs_cor:CapitalStockMember
45470
2025-03-31
jppfs_cor:CapitalSurplusMember
45470
2025-03-31
jppfs_cor:NonControllingInterestsMember
45470
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45470
2025-03-31
jppfs_cor:RetainedEarningsMember
45470
2025-03-31
jppfs_cor:ShareholdersEquityMember
45470
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
45470
2025-03-31
jppfs_cor:TreasuryStockMember
45470
2025-03-31
tse-acedjpfr-45470:InformationServiceReportableSegmentsMember
45470
2025-03-31
tse-acedjpfr-45470:PharmaceuticalProductsReportableSegmentsMember
45470
2025-03-31
tse-acedjpfr-45470:TradingBusinessReportableSegmentMember
45470
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45470
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45470
2024-03-31
45470
2024-03-31
jppfs_cor:CapitalStockMember
45470
2024-03-31
jppfs_cor:CapitalSurplusMember
45470
2024-03-31
jppfs_cor:NonControllingInterestsMember
45470
2024-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45470
2024-03-31
jppfs_cor:RetainedEarningsMember
45470
2024-03-31
jppfs_cor:ShareholdersEquityMember
45470
2024-03-31
jppfs_cor:TreasuryStockMember
45470
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45470
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure